Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 23% ± 7% | |
| epithelial cell | 4 studies | 36% ± 12% | |
| ciliated cell | 4 studies | 29% ± 7% | |
| B cell | 3 studies | 17% ± 1% | |
| fibroblast | 3 studies | 23% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 24% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 531.88 | 180 / 180 | 100% | 36.76 | 430 / 430 |
| prostate | 100% | 767.59 | 245 / 245 | 100% | 27.79 | 502 / 502 |
| skin | 100% | 904.05 | 1809 / 1809 | 100% | 23.26 | 472 / 472 |
| uterus | 100% | 615.89 | 170 / 170 | 100% | 28.39 | 459 / 459 |
| esophagus | 100% | 565.31 | 1444 / 1445 | 100% | 27.38 | 183 / 183 |
| brain | 100% | 675.66 | 2640 / 2642 | 100% | 34.41 | 705 / 705 |
| kidney | 100% | 688.54 | 89 / 89 | 100% | 17.37 | 900 / 901 |
| thymus | 100% | 864.57 | 653 / 653 | 100% | 22.22 | 604 / 605 |
| intestine | 100% | 517.64 | 966 / 966 | 100% | 23.64 | 526 / 527 |
| liver | 100% | 391.96 | 226 / 226 | 100% | 13.75 | 405 / 406 |
| breast | 100% | 666.71 | 459 / 459 | 100% | 29.26 | 1115 / 1118 |
| stomach | 100% | 483.57 | 358 / 359 | 100% | 25.01 | 286 / 286 |
| pancreas | 100% | 366.45 | 327 / 328 | 100% | 21.01 | 178 / 178 |
| bladder | 100% | 554.81 | 21 / 21 | 100% | 27.30 | 502 / 504 |
| lung | 99% | 534.79 | 575 / 578 | 100% | 25.50 | 1155 / 1155 |
| adrenal gland | 100% | 969.95 | 258 / 258 | 98% | 22.87 | 226 / 230 |
| adipose | 100% | 623.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 17.63 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 23.56 | 29 / 29 |
| spleen | 100% | 620.80 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 25.38 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 20.99 | 1 / 1 |
| blood vessel | 99% | 488.48 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 367.09 | 855 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 331.80 | 787 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 76% | 287.27 | 704 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051123 | Biological process | RNA polymerase II preinitiation complex assembly |
| GO_0060261 | Biological process | positive regulation of transcription initiation by RNA polymerase II |
| GO_0032968 | Biological process | positive regulation of transcription elongation by RNA polymerase II |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0016592 | Cellular component | mediator complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0070847 | Cellular component | core mediator complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0008134 | Molecular function | transcription factor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003712 | Molecular function | transcription coregulator activity |
| Gene name | MED19 |
| Protein name | Mediator of RNA polymerase II transcription subunit 19 (Mediator complex subunit 19) Mediator of RNA polymerase II transcription subunit 19 (Lung cancer metastasis-related protein 1) (Mediator complex subunit 19) |
| Synonyms | MED19AS LCMR1 |
| Description | FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. . FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. . |
| Accessions | A0JLT2 J3KR33 ENST00000337672.9 [A0JLT2-2] I0J7B9 ENST00000645681.2 [A0JLT2-2] ENST00000431606.5 |